These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 6410742

  • 1. Pharmacochemical profile of iopromide.
    Muetzel W, Speck U.
    AJNR Am J Neuroradiol; 1983; 4(3):350-2. PubMed ID: 6410742
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Contrast enhancement pharmacokinetics of six ionic and nonionic contrast media.
    Dean PB, Kivisaari L, Kormano M.
    Invest Radiol; 1983; 18(4):368-74. PubMed ID: 6618828
    [Abstract] [Full Text] [Related]

  • 9. Iopromide. A new non-ionic contrast medium.
    Dawson P, Bradshaw A, Hill C.
    Acta Radiol Diagn (Stockh); 1984; 25(3):253-6. PubMed ID: 6475563
    [Abstract] [Full Text] [Related]

  • 10. Proteinuria following nephroangiography. VII. Comparison between ionic monomeric, monoacidic dimeric and non-ionic contrast media in the dog.
    Törnquist C, Almén T, Golman K, Holtås S.
    Acta Radiol Suppl; 1980; 362():49-52. PubMed ID: 6267893
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A double-blind study of iopromide 300 for peripheral arteriography. Results of a multi-institutional comparison of iopromide with iohexol and iopamidol.
    Druy EM, Bettmann MA, Jeans W.
    Invest Radiol; 1994 May; 29 Suppl 1():S102-5; discussion S106. PubMed ID: 8071036
    [Abstract] [Full Text] [Related]

  • 13. Formulation and clinical introduction of low osmolality contrast media.
    Grainger RG.
    Radiologe; 1981 Jun; 21(6):261-7. PubMed ID: 7268025
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC, Pietsch H, Sieber MA, Ernst R, Lengsfeld P, Ellinghaus P, Jost G.
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [Abstract] [Full Text] [Related]

  • 19. Development of nonionic contrast media.
    Almén T.
    Invest Radiol; 1985 Sep; 20(1 Suppl):S2-9. PubMed ID: 2579043
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.